Christopher Hixon, DO
Dermatology · McKinney, TXNPI 1508126046
Payments from drug & device makers
Across 588 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Journey Medical Corporation$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$1K
- Johnson & Johnson$1K
- AbbVie$962
- Lilly USA, LLC$955
- plus $5K from 26 others
What the payments were for
- Consulting fees$1,50013%
- Food & beverage$10,04184%
- Education$4023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Journey Medical Corporation | 5 | $1,570 |
| Regeneron Healthcare Solutions, Inc. | 62 | $1,339 |
| Sanofi | 71 | $1,248 |
| Johnson & Johnson | 54 | $1,211 |
| AbbVie(2 entities) | 68 | $962 |
| Lilly USA, LLC | 52 | $955 |
| Pfizer | 42 | $631 |
| Sun Pharmaceutical Industries Inc. | 38 | $563 |
| LEO Pharma Inc. | 20 | $409 |
| UCB, Inc. | 23 | $394 |
| Novartis | 14 | $316 |
| Amgen | 14 | $280 |
| Mayne Pharma Commercial LLC | 20 | $266 |
| Incyte Corporation | 17 | $259 |
| Almirall LLC | 18 | $250 |
| Galderma Laboratories, L.p. | 12 | $181 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $172 |
| Prugen, Inc. Pharmaceuticals | 6 | $141 |
| Dermira, Inc. | 6 | $114 |
| E.r. Squibb & Sons, L.L.C. | 6 | $112 |
| EPI Health, LLC | 5 | $84 |
| Arcutis Biotherapeutics, Inc. | 5 | $83 |
| Dermavant Sciences, Inc. | 5 | $78 |
| Boehringer Ingelheim | 3 | $70 |
| Kerecis Limited | 2 | $66 |
| VYNE Pharmaceuticals Inc. | 2 | $43 |
| LNHC, Inc | 2 | $42 |
| Verrica Pharmaceuticals Inc. | 2 | $35 |
| Edwards Lifesciences | 1 | $22 |
| Aclaris Therapeutics, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $13 |
How this compares
$11,943 in reported general payments places this provider in the 70th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $244,242 |
| Fluorouracil | 97 | $6,489 |
| Clobetasol Propionate | 143 | $4,813 |
| Tacrolimus | 21 | $1,979 |
| Doxycycline Hyclate | 71 | $1,567 |
| Ketoconazole | 61 | $1,157 |
| Hydroxychloroquine Sulfate | 16 | $1,073 |
| Triamcinolone Acetonide | 142 | $733 |
| Clindamycin Phosphate | 15 | $352 |
| Minoxidil | 28 | $347 |
| ValacyclovirValacyclovir Hcl | 15 | $318 |
| Mupirocin | 32 | $247 |
| Terbinafine Hcl | 16 | $95 |
| Finasteride | 16 | $79 |
Paid to pharmacies, not to this prescriber.
Other dermatology in McKinney
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.